Table 1.
Group | Con | Sco | Tac | RDP10 | RDP20 | RDP30 | |
---|---|---|---|---|---|---|---|
Weight of Body (g) | 1 day | 21.73 ± 0.08 | |||||
7 days | 29.80 ± 0.35 | 30.43 ± 0.35 | 30.03 ± 0.42 | 30.63 ± 0.45 | 29.82 ± 0.39 | 30.87 ± 0.44 | |
14 days | 32.73 ± 0.50 | 33.00 ± 0.41 | 32.52 ± 0.60 | 33.07 ± 0.56 | 32.85 ± 0.62 | 33.40 ± 0.31 | |
21 days | 34.78 ± 0.68 | 34.90 ± 0.87 | 34.57 ± 0.80 | 34.45 ± 0.58 | 36.15 ± 0.62 | 35.47 ± 0.86 | |
28 days | 36.35 ± 0.94 | 35.42 ± 0.81 | 35.00 ± 0.77 | 35.60 ± 0.52 | 36.73 ± 0.76 | 36.45 ± 0.70 | |
31 days | 36.83 ± 0.79 | 35.77 ± 0.71 | 35.17 ± 0.86 | 35.70 ± 0.55 | 36.50 ± 0.76 | 37.92 ± 0.84 |
Con: non-treated group; Sco: scopolamine 2 mg/kg-treated group; Tac: scopolamine 2 mg/kg + tacrine 10 mg/kg-treated group; RDP10: scopolamine 2 mg/kg + RDP 10 mg/kg-treated group; RDP20: scopolamine 2 mg/kg + RDP 20 mg/kg-treated group; RDP30: scopolamine 2 mg/kg + RDP 30 mg/kg-treated group. All data are the mean ± S.E.M (n = 6 per group). There was no significance between the groups.